Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 4/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29926322 | 0.92 | SIGMAR1 (0.42) | OPRD1OPRM1OPRK1SIGMAR1SLC6A2 | |
| SCHEMBL6423819 | 0.90 | SIGMAR1 (0.41) | OPRD1OPRM1OPRK1SIGMAR1SLC6A2 | |
| SCHEMBL7590414 | 0.90 | SIGMAR1 (0.43) | OPRD1OPRM1OPRK1SIGMAR1SLC6A2 | |
| SCHEMBL1494478 | 0.90 | SIGMAR1 (0.43) | OPRD1OPRM1OPRK1SIGMAR1SLC6A2 | |
| Hydrochloric Acid SCHEMBL28404227 | 0.88 | SIGMAR1 (0.42) | OPRD1OPRM1OPRK1SIGMAR1SLC6A2 | |
| SCHEMBL8529806 | 0.80 | SLC6A3 (0.46) | SIGMAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL19889439 | 0.80 | SLC6A3 (0.46) | SIGMAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL499846 | 0.80 | SLC6A3 (0.50) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4441694 | 0.80 | SLC6A3 (0.50) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL472291 | 0.79 | SLC6A3 (0.49) | SIGMAR1SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110079557-A1 | MATERIALS FOR THE SOLID/LIQUID EXTRACTION OF HEAVY METAL IONS, CONTAINING SUPPORTED N-FUNCTIONALIZED POLYAZACYLOALKANES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2011-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110079557-A1 | MATERIALS FOR THE SOLID/LIQUID EXTRACTION OF HEAVY METAL IONS, CONTAINING SUPPORTED N-FUNCTIONALIZED POLYAZACYLOALKANES | NR2C2, NR2E3, NCOR2 | OPRD1 592/4885OPRM1 590/4885OPRK1 301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.